Kelly Covello, Ph.D. joined Mirati in April 2020 as Vice President, Head of Medical Affairs, bringing in more than 15 years of oncology pharmaceutical industry experience in diverse R&D roles spanning drug discovery, clinical development, and medical strategy.
Currently, there are no issues on this topic.